A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes

Joost Daemen, Peter Wenaweser, Keiichi Tsuchida, Linda Abrecht, Sophia Vaina, Cyrill Morger, Neville Kukreja, Peter Jüni, Georgios Sianos, Gerrit Hellige, Ron T van Domburg, Otto M Hess, Eric Boersma, Bernhard Meier, Stephan Windecker, Patrick W Serruys, Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study The Lancet. ,vol. 369, pp. 667- 678 ,(2007) , 10.1016/S0140-6736(07)60314-6

Alexandre Abizaid, Ran Kornowski, Gary S Mintz, Mun K Hong, Andrea S Abizaid, Roxana Mehran, Augusto D Pichard, Kenneth M Kent, Lowell F Satler, Hongsheng Wu, Jeffrey J Popma, Martin B Leon, The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation Journal of the American College of Cardiology. ,vol. 32, pp. 584- 589 ,(1998) , 10.1016/S0735-1097(98)00286-1

K. Nishio, M. Sakurai, T. Kusuyama, M. Shigemitsu, T. Fukui, K. Kawamura, S. Itoh, N. Konno, T. Katagiri, A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes. Diabetes Care. ,vol. 29, pp. 101- 106 ,(2006) , 10.2337/DIACARE.29.01.06.DC05-1170

John A Dormandy, Bernard Charbonnel, David JA Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray, Eberhard Standl, Robert G Wilcox, Lars Wilhelmsen, John Betteridge, Kåre Birkeland, Alain Golay, Robert J Heine, László Korányi, Markku Laakso, Marián Mokáň, Antanas Norkus, Valdis Pirags, Toomas Podar, André Scheen, Werner Scherbaum, Guntram Schernthaner, Ole Schmitz, Jan Škrha, Ulf Smith, Jan Tatoň, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. The Lancet. ,vol. 366, pp. 1279- 1289 ,(2005) , 10.1016/S0140-6736(05)67528-9

Yoshiaki Aizawa, Jun-ichi Kawabe, Naoyuki Hasebe, Naohumi Takehara, Kenjiro Kikuchi, Pioglitazone Enhances Cytokine-Induced Apoptosis in Vascular Smooth Muscle Cells and Reduces Intimal Hyperplasia Circulation. ,vol. 104, pp. 455- 460 ,(2001) , 10.1161/HC3001.092040

Koichi Tamita, Atsushi Yamamuro, Tsutomu Takagi, Minako Katayama, Shigefumi Morioka, Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study. Journal of Cardiology. ,vol. 45, pp. 139- 147 ,(2005)

Tsutomu Takagi, Kiyoshi Yoshida, Takashi Akasaka, Shuichiro Kaji, Takahiro Kawamoto, Yasuhiro Honda, Atsushi Yamamuro, Takeshi Hozumi, Shigefumi Morioka, Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. Journal of the American College of Cardiology. ,vol. 36, pp. 731- 738 ,(2000) , 10.1016/S0735-1097(00)00799-3

Tsutomu Takagi, Takashi Akasaka, Atsushi Yamamuro, Yasuhiro Honda, Takeshi Hozumi, Shigefumi Morioka, Kiyoshi Yoshida, Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus: A serial intravascular ultrasound study Journal of the American College of Cardiology. ,vol. 36, pp. 1529- 1535 ,(2000) , 10.1016/S0735-1097(00)00895-0

Erland Erdmann, John A Dormandy, Bernard Charbonnel, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, PROactive Investigators, The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study. Journal of the American College of Cardiology. ,vol. 49, pp. 1772- 1780 ,(2007) , 10.1016/J.JACC.2006.12.048

Jacques Machecourt, Nicolas Danchin, Jean Marc Lablanche, Jean Marie Fauvel, Jean Louis Bonnet, Stephanie Marliere, Alison Foote, Jean Louis Quesada, Hélène Eltchaninoff, Gérald Vanzetto, EVASTENT Investigators, Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry. Journal of the American College of Cardiology. ,vol. 50, pp. 501- 508 ,(2007) , 10.1016/J.JACC.2007.04.051